Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.53 | 24.83 |
| PEG Ratio (TTM) | 0.05 | -0.40 |
| P/S Ratio (TTM) | 0.20 | 1.77 |
| P/B Ratio (TTM) | 0.27 | 2.19 |
| P/FCF Ratio (TTM) | -0.40 | 8.62 |
| Price to 5YR AVG Earnings Ratio | N/A | 11.03 |
| Price to 5YR AVG FCF Ratio | N/A | 10.55 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -29.35% | 4.89% |
| ROE (TTM) | -43.41% | 16.10% |
| Net Profit Margin (TTM) | -37.91% | -28.67% |
| ROIC 5YR AVG | N/A | 21.40% |
Growth (10%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -19.40% | -81.81% | N/A |
| Revenue | -12.89% | 50.47% | N/A |
| Net Income | -19.61% | -91.92% | N/A |
| Cash Flow | -9,402.35% | 1.15% | N/A |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.29 | 2.10 |
| Quick Ratio (TTM) | 3.38 | 0.90 |
| D/E Ratio (TTM) | 0.06 | 0.83 |
| Interest Coverage (TTM) | -52.73 | 1.37 |
| Piotroski F-Score | 3 | 6 |
| Altman Z-Score | N/A | 3.54 |
| LTL to 5YR AVG FCF | N/A | 4.94 |
| Shares Outstanding Growth 5YR AVG | N/A | -1.88% |